FLFei Liu

Fei Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fei Liu has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Suping Wang

    Stomatology Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China

    4 shared publications
  • Yiyi Wang

    Stomatology Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    4 shared publications
  • Lixin Fang

    Stomatology Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    3 shared publications
  • Hao Zheng

    Stomatology Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    2 shared publications
  • Huoxiang Zhou

    Laboratory of Microbiology and Immunology, Institute of Medical and Pharmaceutical Sciences & BGI College, Zhengzhou University, Zhengzhou 450052, China; Henan Key Laboratory of Child Brain Injury and Henan Pediatric Clinical Research Center, The Third Affiliated Hospital and Institute of Neuroscience, Zhengzhou University, Zhengzhou 450052, China

    2 shared publications
  • Lei Cheng

    Department of Cariology and Endodontics, State Key Laboratory of Oral Diseases and National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University., Cheng Du, China

    2 shared publications

Latest Publications

  • Open Access

    Recent progress in antimicrobial strategies of controlled-release nanomaterials for secondary caries

    by Yiyi Wang, Xushuo Du, Yanmin Jia, Lu Qin, Fei Liu, Yingchun Cai, Suping Wang

    Secondary caries is a leading cause of restoration failure. Inhibiting caries through antimicrobial efficacy is essential for extending the restoration’s service life. Antimicrobial agents have been incorporated into restorative materials for decades. Based on their mechanism of antimicrobial action, these materials are classified as either releasing or non-releasing types. However, the simple release strategy is often insufficient for long-term caries prevention, as it lacks the precision, durability, and adaptability now required. This necessitates the development of next-generation systems that can provide a controlled, sustained, and targeted antimicrobial activity. To this end, this review focuses on advanced, controlled-release antimicrobial strategies, exploring the design of novel nanomaterials, their functional efficacy, and the mechanisms of their representative antimicrobial agents.


  • Open Access

    Silica nanoparticles containing nano-silver and chlorhexidine to suppress Porphyromonas gingivalis biofilm and modulate multispecies biofilms toward healthy tendency

    by Lixin Fang, Yishuang Zhang, Long Cheng, Hao Zheng, Yiyi Wang, Lu Qin, Yingchun Cai, Lei Cheng, Wen Zhou, Fei Liu, et al.

    This research first investigated the effect of mesoporous silica nanoparticles (nMS) carrying chlorhexidine and silver (nMS-nAg-Chx) on periodontitis-related biofilms. This study aimed to investigate (1) the antibacterial activity on Porphyromonas gingivalis (P. gingivalis) biofilm; (2) the suppressing effect on virulence of P. gingivalis biofilm; (3) the regulating effect on periodontitis-related multispecies biofilm. Silver nanoparticles (nAg) and chlorhexidine (Chx) were co-loaded into nMS to form nMS-nAg-Chx. Inhibitory zone test and minimum inhibitory concentration (MIC) against P. gingivalis were tested. Growth curves, crystal violet (CV) staining, live/dead staining and scanning electron microscopy (SEM) observation were performed. Biofilm virulence was assessed. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay and Quantitative Real Time-PCR (qPCR) were performed to validate the activity and composition changes of multispecies biofilm (P. gingivalis, Streptococcus gordonii and Streptococcus sanguinis). nMS-nAg-Chx inhibited P. gingivalis biofilm dose-dependently (p<0.05), with MIC of 18.75 µg/mL. There were fewer live bacteria, less biomass and less virulence in nMS-nAg-Chx groups (p<0.05). nMS-nAg-Chx inhibited and modified periodontitis-related biofilms. The proportion of pathogenic bacteria decreased from 16.08 to 1.07% and that of helpful bacteria increased from 82.65 to 94.31% in 25 μg/mL nMS-nAg-Chx group for 72 h. nMS-nAg-Chx inhibited P. gingivalis growth, decreased biofilm virulence and modulated periodontitis-related multispecies biofilms toward healthy tendency. pH-sensitive nMS-nAg-Chx inhibit the pathogens and regulate oral microecology, showing great potential in periodontitis adjunctive therapy.


  • Open Access

    Silica nanoparticles containing nano-silver and chlorhexidine respond to pH to suppress biofilm acids and modulate biofilms toward a non-cariogenic composition

    by Suping Wang, Lixin Fang, Huoxiang Zhou, Man Wang, Hao Zheng, Yiyi Wang, Michael D. Weir, Radi Masri, Thomas W. Oates, Lei Cheng, et al.


  • Open Access

    The application of mesoporous silica nanoparticles as a drug delivery vehicle in oral disease treatment

    by Lixin Fang, Huoxiang Zhou, Long Cheng, Yiyi Wang, Fei Liu, Suping Wang

    Mesoporous silica nanoparticles (MSNs) hold promise as safer and more effective medication delivery vehicles for treating oral disorders. As the drug’s delivery system, MSNs adapt to effectively combine with a variety of medications to get over systemic toxicity and low solubility issues. MSNs, which operate as a common nanoplatform for the co-delivery of several compounds, increase therapy effectiveness and show promise in the fight against antibiotic resistance. MSNs offer a noninvasive and biocompatible platform for delivery that produces long-acting release by responding to minute stimuli in the cellular environmen. MSN-based drug delivery systems for the treatment of periodontitis, cancer, dentin hypersensitivity, and dental cavities have recently been developed as a result of recent unparalleled advancements. The applications of MSNs to be embellished by oral therapeutic agents in stomatology are discussed in this paper.